Denali Therapeutics (DNLI) Technical (Analysis) Reports Denali Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Denali Therapeutics (DNLI)
Technical Analysis Report for USA stock DNLI Denali Therapeutics. Dated: 28 Feb 2025 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock DNLI Denali Therapeutics then click here. or read Experts views on Denali Therapeutics or Forecast & share price targets of Denali Therapeutics
Denali Therapeutics Opened at 18.83 and Closed at: 16.56, which is -12.32% of previous session's close. It moved within a range of 16.32 and 19.00
The session was a Bearish session with an average volume of 2241700, which is 63.6% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- There is some negative change in the long term trend, but its too soon to jump onto conclusions.
Support for tomorrow is 15.1 and resistance for tomorrow is 17.78
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 15.59, 14.61 resistance for tomorrow's hourly charts is 18.27, 19.97
10 Day SMA for Denali Therapeutics (DNLI) is 20.25 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Denali Therapeutics (DNLI) is 21.03 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Denali Therapeutics (DNLI) is 21.3 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 23.82 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Denali Therapeutics is 23.67 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Denali Therapeutics is at 21.03 and 200 DMA is at 23.67, while 50 DMA and 100 DMA are at 21.3 and 23.82 respectively
Denali Therapeutics (DNLI) moving average of 20 SMA is at 21.03 and 20 EMA is at 20.55
Date | Closing Price | 20 SMA | 20 EMA |
28 Fri Feb | 16.56 | 21.03 | 20.55 |
27 Thu Feb | 18.60 | 21.37 | 20.97 |
26 Wed Feb | 18.89 | 21.62 | 21.22 |
25 Tue Feb | 19.20 | 21.84 | 21.47 |
24 Mon Feb | 20.67 | 22.06 | 21.71 |
21 Fri Feb | 20.73 | 22.19 | 21.82 |
Denali Therapeutics (DNLI) moving average of 50 SMA is at 21.3 and 50 EMA is at 21.72
Date | Closing Price | 50 SMA | 50 EMA |
28 Fri Feb | 16.56 | 21.3 | 21.72 |
27 Thu Feb | 18.60 | 21.4 | 21.93 |
26 Wed Feb | 18.89 | 21.45 | 22.07 |
25 Tue Feb | 19.20 | 21.54 | 22.2 |
24 Mon Feb | 20.67 | 21.62 | 22.32 |
21 Fri Feb | 20.73 | 21.67 | 22.39 |
Denali Therapeutics (DNLI) moving average of 100 SMA is at 23.82 and 100 EMA is at 22.74
Date | Closing Price | 100 SMA | 100 EMA |
28 Fri Feb | 16.56 | 23.82 | 22.74 |
27 Thu Feb | 18.60 | 23.94 | 22.86 |
26 Wed Feb | 18.89 | 24.05 | 22.95 |
25 Tue Feb | 19.20 | 24.15 | 23.03 |
24 Mon Feb | 20.67 | 24.25 | 23.11 |
21 Fri Feb | 20.73 | 24.34 | 23.16 |
Denali Therapeutics (DNLI) moving average of 200 SMA is at 23.67 and 200 EMA is at 22.98
Date | Closing Price | 200 SMA | 200 EMA |
28 Fri Feb | 16.56 | 23.67 | 22.98 |
27 Thu Feb | 18.60 | 23.69 | 23.04 |
26 Wed Feb | 18.89 | 23.68 | 23.08 |
25 Tue Feb | 19.20 | 23.68 | 23.12 |
24 Mon Feb | 20.67 | 23.68 | 23.16 |
21 Fri Feb | 20.73 | 23.66 | 23.19 |
Takeda Pharmaceutical has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Takeda Pharmaceutical, about 32.93% more returns!
Perrigo Company has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Perrigo Company, about 39.76% more returns!
Globus Medical has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Globus Medical, about 10.93% more returns!
Biohaven Pharmaceutical has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Biohaven Pharmaceutical, about 22.77% more returns!
Voyager Therapeutics has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Voyager Therapeutics, about 0.73% more returns!
Supernus Pharmaceuticals has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Supernus Pharmaceuticals, about 9.99% more returns!
Sangamo Therapeutics has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Sangamo Therapeutics, about 11.36% more returns!
Organogenesis Holdings has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Organogenesis Holdings, about 106.29% more returns!
Microbot Medical has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Microbot Medical, about 2.08% more returns!
Masimo Corporation has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Masimo Corporation, about 33.84% more returns!
Incyte Corporation has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Incyte Corporation, about 23.85% more returns!
Galectin Therapeutics has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Galectin Therapeutics, about 51.82% more returns!
Autolus Therapeutics has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Autolus Therapeutics, about 6.17% more returns!
Assertio Therapeutics has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Assertio Therapeutics, about 20.48% more returns!
Assembly Biosciences has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Assembly Biosciences, about 17.51% more returns!
Aquestive Therapeutics has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Aquestive Therapeutics, about 21.07% more returns!
Apyx Medical has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Apyx Medical, about 26.29% more returns!
Aceto Corporation has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Aceto Corporation, about 24.18% more returns!
Acadia Pharmaceuticals has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Acadia Pharmaceuticals, about 30.07% more returns!
Denali Therapeutics Technical analysis of indicators
Price action analysis of Denali Therapeutics (DNLI) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Denali Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Denali Therapeutics in short term and the sell signal is strong.
Denali Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Denali Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Denali Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 19.55 and Denali Therapeutics DNLI stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Denali Therapeutics DNLI stock. Volume based technical analysis of Denali Therapeutics DNLI stock is negative.
Denali Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock DNLI Denali Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And DNLI Experts View which covers a lot of information including buying and selling signals
DNLI future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Denali Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Denali Therapeutics (DNLI) Technical (Analysis) Reports Denali Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance